What is the incidence of post-infectious inflammatory bowel disease (PI-IBD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Post-Infectious Inflammatory Bowel Disease

I need to clarify an important distinction: the question asks about post-infectious inflammatory bowel disease (PI-IBD), but all available evidence addresses post-infectious irritable bowel syndrome (PI-IBS), which is a fundamentally different condition. True inflammatory bowel disease (IBD) refers to Crohn's disease and ulcerative colitis, which are chronic inflammatory conditions with distinct pathophysiology from functional disorders like IBS.

Post-Infectious IBS (Not IBD) Incidence

Based on the Rome Foundation guidelines, approximately 10.1% of patients develop post-infectious IBS within 12 months following infectious enteritis, with this prevalence increasing to 14.5% beyond 12 months. 1, 2

Key Epidemiologic Data

  • Overall range: The prevalence among those suffering from infectious enteritis ranges between 4-36%, with significant variation based on pathogen type and geographic location 1, 2, 3

  • Relative risk: Patients face a 4.2-fold increased risk of developing IBS compared to uninfected individuals within 12 months, which decreases to 2.3-fold beyond 12 months 1, 2, 3

  • Pooled data: A systematic review of 45 studies comprising approximately 21,000 individuals with enteritis found the pooled prevalence of IBS at 12 months was 10.1% (95% CI, 7.2-14.1) 1

Pathogen-Specific Variations

  • Bacterial infections carry higher risk than viral infections, despite viral gastroenteritis being more common overall 1, 4

  • Clostridium difficile: Up to 25% of patients develop PI-IBS following C. difficile infection 1, 5

  • Vibrio cholerae: Associated with PI-IBS development in 16.5% of cases 1, 4

  • Norovirus: One prospective cohort study found 13% incidence of PI-IBS following a Norovirus outbreak 6

Important Clinical Caveat

The evidence provided does not address true post-infectious inflammatory bowel disease (Crohn's disease or ulcerative colitis developing after infection). While infections may trigger or unmask underlying IBD in susceptible individuals, this is a separate phenomenon from PI-IBS, which is a functional disorder without the chronic inflammation, ulceration, and structural changes characteristic of IBD. If you are specifically asking about new-onset Crohn's disease or ulcerative colitis following infection, different literature would be needed to answer that question accurately.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Post-Infectious Irritable Bowel Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Long-Term Effects of Enteroaggregative E. coli After Infection Clearance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Enteritis Causes and Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Post-infectious ibs following Clostridioides difficile infection; role of microbiota and implications for treatment.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.